Effect of pemafibrate on lipid and bile acid metabolism in patients with fatty liver or primary biliary cholangitis
Not Applicable
Recruiting
- Conditions
- fatty liver, PBC
- Registration Number
- JPRN-UMIN000039125
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. severe liver dysfunction (C-P B or C) 2. moderate or severe renal dysfunction 3. gallstone 4. pregnant women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hepatic fat evaluated by MRS in 6 months (fatty liver patients) Serum ALP levels in 6 months (PBC patients)
- Secondary Outcome Measures
Name Time Method